康德萊(603987.SH)擬通過增資和股權轉讓方式取得瑞琦科技51%股權
格隆匯12月26日丨康德萊(603987.SH)發佈公告,為了進一步實現基礎耗材的“產業多元共生戰略”,提高公司的競爭力和盈利能力,公司全資子公司廣東康德萊擬以自有資金通過增資和股權轉讓方式,取得成都瑞琦醫療科技有限責任公司本次增資後合計51%股權。本次交易中涉及的增資與股權轉讓互為前提,不可分割,兩個步驟互為前提,其中一個步驟未能完成的,另外一個步驟自動取消。本次增資及股權轉讓的定價以瑞琦科技評估報告所確定的評估值為依據確定。經各方友好協商,瑞琦科技100%股權整體作價確定為人民幣1.27億元,據此確定本次交易增資及股權轉讓基準定價為每一元註冊資本對應人民幣6.3500元。本次交易完成後,公司將持有瑞琦科技51%股權,其將納入公司合併報表範圍。
根據披露,成都瑞琦醫療科技有限責任公司(原名:成都瑞琦科技實業股份有限公司)主要從事臨牀檢驗標本採集產品、微生物培養基產品和細胞染液及多功能自動染片機等的研發、生產和銷售,以及國內外醫療器械產品的代理銷售。
公告表示,本次交易將有助於整合發揮廣東康德萊和標的公司的業務協同效應,充實華南製造基地的產品線與業務規模,有利於提高公司的競爭力。本次交易完成後,公司將持有瑞琦科技51%股權,其將納入公司合併報表範圍,預計會給公司帶來新的利潤增長點,對公司財務狀況和經營成果產生有利影響。公司不存在為瑞琦科技擔保、委託其為公司理財,瑞琦科技也不存在佔用上市公司資金等方面的情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.